Zhen Zhuang Cheng

Title: Zhen Zhuang Cheng: Innovator in Cardiac Therapeutics

Introduction

Zhen Zhuang Cheng is a prominent inventor based in Elmhurst, NY (US). He has made significant contributions to the field of cardiac therapeutics, holding a total of 3 patents. His work focuses on developing innovative drugs aimed at treating heart-related conditions.

Latest Patents

Cheng's latest patents include groundbreaking methods for creating anti-arrhythmic and heart failure drugs that specifically target the leak in the ryanodine receptor (RyR2). One of his notable inventions provides methods for limiting or preventing a decrease in the level of RyR2-bound FKBP12.6 in a subject. This invention also outlines methods for treating and preventing atrial and ventricular cardiac arrhythmias, heart failure, and exercise-induced sudden cardiac death. Additionally, he has developed uses for JTV-519 in methods aimed at preventing decreases in RyR2-bound FKBP12.6 levels in patients with atrial fibrillation. His other patent focuses on novel compounds that regulate calcium channel functioning in cells, addressing various disorders including cardiac, skeletal muscular, and cognitive diseases.

Career Highlights

Zhen Zhuang Cheng is affiliated with Columbia University, where he continues to advance research in cardiac therapeutics. His innovative approaches have positioned him as a key figure in the development of new treatments for heart-related disorders.

Collaborations

Cheng collaborates with esteemed colleagues such as Donald W. Landry and Shixian Deng, contributing to a dynamic research environment that fosters innovation in medical science.

Conclusion

Zhen Zhuang Cheng's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cardiac therapeutics. His patents reflect a commitment to improving patient outcomes through advanced medical research.